You are here: Industry Insights > mRNA

News List

Genmab, CureVac Enter Partnership to Develop mRNA-based Antibody Therapeutics americanpharmaceuticalreview
December 23, 2019
Genmab and CureVac have entered into a research collaboration and license agreement. This strategic partnership will focus on the research and development of ...
CureVac, Yale Collaborate on Discovery Research contractpharma
August 14, 2019
Will focus on developing novel mRNA-based candidates for pulmonary diseases.
Sanofi invests €80M in BioNTech as cancer mRNA hits clinic fiercebiotech
January 07, 2019
Sanofi is set to invest €80 million ($91 million) in BioNTech and extend its cancer collaboration with the German mRNA specialist. The agreement comes as BioNTech and Sanofi prepare to .....
Moderna’s cash juggernaut rolls on with record $604M IPO fiercebiotech
December 28, 2018
Moderna’s IPO always looked like a record breaker for biotech and came in even larger than expected at $604 million, valuing the company at an eye-watering $7.9 billion.....
BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza pharmafocusasia
November 27, 2018
BioNTech AG, a rapidly growing biotechnology company focused on precise immunotherapies for the treatment of cancer and infectious disease...
Jobs and Elon Musk in the Life Sciences Community? Stephen Hoge will Disrupt the Entire Monoclonal Antibody Industry with mRNA Therapy Chen Bin
September 21, 2018
Stephen Hoge will Disrupt the Entire Monoclonal Antibody Industry with mRNA Therapy
Moderna grabs $125M in expanded Merck cancer vaccine collaboration fiercebiotech
May 07, 2018
On the heels of a massive $500 million round, Moderna has picked up another $125 million in preferred equity as it expands its mRNA cancer vaccine partnership with Merck.
Study Reveals Huge Potential for mRNA Drug Targets biospace
March 20, 2018
Companies that have a strong focus on developing drugs that target messenger RNA (mRNA) may be ahead of the curve when it comes to potentially tapping into a lucrative market space.
With Merck Footing the $200M Bill, Moderna Launches mRNA Cancer Vaccine Clinical Trial biospace
November 17, 2017
Moderna Therapeutics announced that it has dosed its first patient in a Phase I trial of mRNA-4157, a messenger RNA (mRNA)-based personalized cancer vaccine.
Lilly, CureVac pen $1.8B mRNA cancer vaccine deal fiercebiotech
October 19, 2017
Lilly is making a $50 million upfront payment and €45 million equity investment to get the deal up and running.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page